Spatial transcriptomic profiling of coronary endothelial cells in SARS-CoV-2 myocarditis
暂无分享,去创建一个
A. Gaggar | J. Wells | L. Viera | C. Goffinet | C. Margaroli | Chunyan Song | G. A. Payne | R. Patel | P. Benson | M. G. Gastanadui | Chunyan Song | D.D. Xing | U. Martin | M. Gastanadui | Camilla Margaroli
[1] T. Assimes,et al. A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility , 2022, NPJ genomic medicine.
[2] Q. Su,et al. Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives , 2022, Advances in Protein Chemistry and Structural Biology.
[3] P. Kirchhof,et al. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart , 2021, Cardiovascular research.
[4] Xiaomin Wang,et al. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01 , 2021, EClinicalMedicine.
[5] P. Libby,et al. Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis , 2021, The American Journal of Pathology.
[6] L. Dölken,et al. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro , 2021, Frontiers in Cellular and Infection Microbiology.
[7] M. Mirsaeidi,et al. COVID-19 and Cardiomyopathy: A Systematic Review , 2021, Frontiers in Cardiovascular Medicine.
[8] T. Assimes,et al. IL10RB as a key regulator of COVID-19 host susceptibility and severity , 2021, medRxiv.
[9] H. Keyvani,et al. Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions , 2021, BioMed research international.
[10] Timothy L. Tickle,et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets , 2021, Nature.
[11] B. Lie,et al. The influence of HLA genotype on the severity of COVID‐19 infection , 2021, HLA.
[12] A. Gaggar,et al. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures , 2021, Cell Reports Medicine.
[13] M. Diamond,et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis , 2021, JACC: Basic to Translational Science.
[14] Nicky Phillips,et al. The coronavirus is here to stay — here’s what that means , 2021, Nature.
[15] J. Haas,et al. Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells , 2021, Circulation.
[16] H. Moch,et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart , 2021, EBioMedicine.
[17] Dingyu Zhang,et al. The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019 , 2020, Critical Care.
[18] M. Diamond,et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis , 2020, bioRxiv.
[19] L. Papazian,et al. Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19 , 2020, The Journal of infectious diseases.
[20] D. Lewis,et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives , 2020, Nature Reviews Cardiology.
[21] Sharon J Peacock,et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[22] Karlheinz Peter,et al. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications , 2020, Circulation research.
[23] P. Carmeliet,et al. COVID-19: the vasculature unleashed , 2020, Nature Reviews Immunology.
[24] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[25] Hongliang Li,et al. The Science Underlying COVID-19: Implications for the Cardiovascular System. , 2020, Circulation.
[26] J. Manson,et al. Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases , 2013, Genome Medicine.
[27] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[28] B. Berk,et al. Angiotensin II and the Endothelium: Diverse Signals and Effects , 2005, Hypertension.
[29] R. Hynes,et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] Robert C. Wolpert,et al. A Review of the , 1985 .